Charged Alpha Stock Encyclopedia

Becton Dickinson (BDX) Q3 FY2026 — Q3 FY2026 (quarter ended June 30, 2026): revenue $4,983M vs $4,726M, +5.4% reported and +4.4% currency-neutral, against a $4,887M bar - a 2.0% beat. GAAP diluted EPS from continuing operations $1.64 vs $1.57 (+4.5%); adjusted diluted EPS $3.23 vs $3.08 (+4.9%), against a $3.14 bar - a nine-cent BEAT. Total GAAP EPS including discontinued operations $1.37. FY2026...

Royal Gold (RGLD) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): revenue $450.5M vs $209.6M, up 114.9%, but 1.8% BELOW the $458.85M Street bar. GAAP EPS $2.78 vs $2.01; adjusted EPS $2.56 vs $1.81, against a $2.55 bar - a one-cent beat. GEOs sold 100,000 vs 63,900 (+56.5%). Record operating cash flow $335.2M. The 8-K was accepted at 5:14 p.m. ET Wednesday Aug 5, so Thursday Aug 6 was the reactio...

Zoetis (ZTS) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): revenue $2.468B vs $2.474B, flat reported and -1% organic operational, against a ~$2.50B Street bar (a 1.3% MISS). GAAP EPS $1.65 vs $1.63; adjusted EPS $1.87 vs $1.78, against a $1.85 bar. But adjusted NET INCOME fell 1%, from $791M to $781M - diluted shares went 445.5M to 417.7M. Companion Animal revenue -$82M; Livestock +$80M; total...

Republic Services (RSG) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): revenue $4.430B vs $4.235B, +4.6%, against a ~$4.41B Street bar. GAAP EPS $1.84 vs $1.75; adjusted EPS $1.85 vs $1.77, against a $1.81-$1.83 bar. Adjusted EBITDA $1.423B, margin 32.1%, flat YoY. Operating income $901M, +4.6%. But income before income taxes was $699M vs $720M, DOWN 2.9%, with the effective tax rate falling 23....

Halozyme Therapeutics (HALO) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): total revenue $481.0M vs $325.7M, +47.7%, against a ~$402M Street bar. Royalties $307.7M, +49.6%; product sales $129.6M, +59.0%. GAAP EPS $1.90 vs $1.33; non-GAAP net income $272.6M / $2.28 diluted EPS vs $191.3M / $1.54, against a $1.79 bar. Adjusted EBITDA $328.8M vs $225.5M, +45.8%, a 68.4% margin. Non-GAAP diluted sh...

Paycom (PAYC) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): revenue $531.2M vs $483.6M, +9.8%, against a ~$513.1M Street bar. Recurring and other revenue $505.2M, +11.0%, 95.1% of the total; interest on funds held for clients $26.0M vs $28.5M, DOWN 8.8%. GAAP net income $107.4M / $2.34 diluted EPS vs $89.5M / $1.58. Non-GAAP net income $127.7M / $2.78 diluted EPS vs $116.6M / $2.06, against a $...

Sempra (SRE) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): GAAP earnings $796M / $1.21 diluted EPS vs $461M / $0.71. Adjusted earnings $762M / $1.16 adjusted diluted EPS vs $583M / $0.89, against a Street bar of $1.07 - a $0.09 beat. Revenue $2,997M vs $3,000M, essentially flat, and 6.9% below the ~$3.22B consensus. Equity earnings $547M vs $393M. 2026 GAAP EPS guidance raised to $5.02-$5.55; 2...

Novo Nordisk A/S (NVO) Q2 2026 — Q2 2026 (quarter ended June 30, 2026), reported in Danish kroner: adjusted net sales DKK 78,488M, +7% at constant currency. Adjusted operating profit DKK 33,389M, +11% CER. Adjusted diluted EPS per ADR DKK 6.18 against a bar worth about DKK 5.01 - a 23% beat. IFRS diluted EPS was DKK 4.75, DOWN 20%; the gap is DKK 6,328M of non-cash pipeline impairments. FY2026 gui...

Insulet Corporation (PODD) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): revenue $801.7M +23.5% (+22.7% constant currency), which cleared the TOP of Insulet's own 20-22% guide. Adjusted EPS $1.66 +41.5% vs a $1.47 bar (+12.9% beat). GAAP EPS $1.37 - the $0.29 gap is recall warranty cost. Adjusted gross margin 72.9%, a company record. FY2026 adjusted EPS guidance was RAISED from more than 25% gr...

Elanco Animal Health (ELAN) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): revenue $1,368M +10% (+8% organic constant currency), adjusted EPS $0.34 +31% vs a $0.27 bar, GAAP EPS $0.11, adjusted EBITDA $288M +21% at a 21.2% margin. FY2026 guidance RAISED for the third straight quarter to $5.09-5.14B revenue and $1.10-$1.16 adjusted EPS. The 8-K was accepted 6:27 a.m. ET on Aug 5 (before the open)...

W.W. Grainger (GWW) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): net sales $5,021M +10.3% (+13.7% daily organic constant currency), diluted EPS $12.01 +20.5% vs a ~$11.30 bar, operating margin 16.1% (+120bps). FY2026 guidance RAISED on every line, EPS to $45.50-$47.25. The 8-K was accepted 8:03 a.m. ET on Aug 4 (before the open), so the reaction is in the tape: GWW fell 5.16% that day, $1,371....

Albemarle Corporation (ALB) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): net sales $1,743.3M, +31.1% y/y, vs a $1,606.9M bar (+8.5%). Adjusted diluted EPS $3.75 vs $3.20 (+17.2%). GAAP diluted EPS $3.52. Adjusted EBITDA $858.1M, +155%, a 49.2% margin. Energy Storage sales +$559.0M on volume +11.0% (59 to 65 kT LCE) and realized price +60.5% ($12.17 to $19.53/kg) - so ~$478M, 86%, is price. Inc...

Nova Ltd (NVMI) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): revenue $254.958M, +15.9% y/y, the TOP of the $245-255M guide. Non-GAAP diluted EPS $2.51 vs a $2.41 bar. GAAP diluted EPS $2.20, up only 2.8% on net income that rose 9.8% (diluted shares +7.5%). Non-GAAP gross margin 58.1%, down from 60.0%. H1 operating cash flow $81.0M vs $114.2M, -29.1%. Receivables +38.4% since December; DSO 63 t...

Take-Two Interactive Software (TTWO) Q1 FY2027 — Q1 FY2027 (quarter ended June 30, 2026): net bookings $1,385.9M, DOWN 2.6% y/y, above the $1,320-1,370M guide. GAAP net revenue $1,533.9M (+2.0%). GAAP EPS -$0.18 vs a -$0.21 consensus. Management-basis EPS $0.35, computed off the company's own reconciliation. Gross margin 57.5%, down from 62.8%, including a $43.4M title impairment. Operating cash f...

Applied Optoelectronics (AAOI) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): revenue $191.9M, +86.4% y/y and +27.0% sequentially, a fifth straight record. Non-GAAP EPS $0.06 vs a ~$0.015 bar; GAAP EPS -$0.28 (net loss $22.8M). GAAP gross margin 27.7%, DOWN from 30.3% y/y and 29.1% q/q. Operating loss -$24.7M vs -$16.0M. Adjusted EBITDA -$0.5M. The 8-K was accepted 4:13 p.m. ET on Aug 6 (AMC), s...

HubSpot (HUBS) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): non-GAAP EPS $3.26 vs a $3.02 bar (+8%), up 49% y/y; GAAP EPS $0.86 vs -$0.06. Revenue $911.7M (+20% reported, +17% cc) vs $898M expected. Non-GAAP operating margin 20.3% vs 17.0%. The 8-K was accepted 4:15 p.m. ET on Aug 5 (AMC), so the Aug 6 close of $202.43 IS the reaction - down 19.1% from $250.21, the largest one-day fall in HubS...

ConocoPhillips (COP) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): adjusted diluted EPS $3.24 vs a ~$2.89 bar (+12%), up 128% y/y; GAAP EPS $3.23. Revenue $19.5B (+32.4%). CFO $7.4B, capex $3.0B, FCF $4.4B. Production 2,248 MBOED, DOWN 6% y/y. Realized $62.33/BOE, +36%. The 8-K was accepted 7:23 a.m. ET on Aug 6, so the $116.76 close IS the reaction - and the stock rose only 1.5% on a day Brent...

Onto Innovation Inc. (ONTO) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): revenue $343.1M, +35.3% y/y vs a $325.3M bar. Non-GAAP diluted EPS $1.93 vs $1.69 (+14.2%); GAAP diluted EPS $1.21 (+75%). Non-GAAP operating margin 30.0%. The May guide was $320-330M / $1.65-1.73 - the print cleared the HIGH END of all four metrics. The 8-K was accepted 4:09 p.m. ET on Aug 6, so the $268.70 close is the...

The Williams Companies, Inc. (WMB) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): revenue $3,053M, +9.8% y/y vs a tracked $2,828M bar. GAAP diluted EPS $0.68 (+51%); ADJUSTED diluted EPS $0.50 (+8%) against a $0.52 Zacks bar - so the adjusted line was a small MISS. Adjusted EBITDA $1,921M (+6.2%). AFFO $1,450M (+10.1%). Leverage 3.67x. The 8-K landed 4:18 p.m. ET Monday Aug 3, so the $71.51 clos...

TTM Technologies, Inc. (TTMI) Q2 2026 — Q2 2026 (quarter ended June 29, 2026): revenue $1,004.1M, +37.4% y/y - the first billion-dollar quarter in TTM's history, and $34M above the HIGH end of its own $930-970M guide. Non-GAAP diluted EPS $0.99 vs a ~$0.89 bar and its own $0.82-0.88 guide; GAAP diluted $0.77 after a $14.0M non-cash swap mark. Adjusted EBITDA $166.8M (16.6%). Book-to-bill 1.49. The...

EOG Resources, Inc. (EOG) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): revenue $8,620M, +57% y/y and 7.1% above the $8,045M estimate. Adjusted diluted EPS $5.07 vs a $4.97 bar (GAAP diluted $5.15 - the adjustments REDUCE earnings by $0.08). Free cash flow $2,799M vs $973M a year ago. Production 1,410.4 MBoed, +24.4%, but crude only +8.8%. Realised US oil $98.18/Bbl vs $64.84. Buyback authorisa...

Texas Pacific Land Corporation (TPL) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): revenue $246.1M, +31.2% y/y but below the $249.5M estimate. GAAP diluted EPS $2.23 vs a $2.18 bar (TPL publishes no non-GAAP EPS). Record net income $153.9M, record free cash flow $155.5M. Realised oil $97.55/Bbl vs $70.57 in Q1 - but oil volumes fell 4.8%, gas realised $0.40/Mcf, water sales fell 18%, and produc...

ResMed Inc. (RMD) Q4 FY2026 — Q4 FY2026 (quarter ended June 30, 2026): revenue $1,463.6M, +9% reported and +8% constant currency, just ahead of a $1,461.3M estimate. GAAP diluted EPS $2.64; NON-GAAP diluted EPS $2.95 vs a $2.89 non-GAAP bar - a 2% BEAT, not the 9% miss some outlets printed off the GAAP number. The 31-cent gap is $41.9M of Astral Class 1 recall expense. FY2026: revenue $5,653M +10%...

Solventum Corporation (SOLV) Q2 2026 — Q2 2026 (quarter ended June 30, 2026): sales $2,209M, +2.2% reported and +9.5% organic, ~2.6% ahead of a $2,154M estimate. Adjusted diluted EPS $2.55 vs a $1.90 bar - a 34% BEAT. GAAP diluted EPS $0.53. Adjusted operating margin 28.4% vs 21.9%. Free cash flow $144M in the quarter but MINUS $129M for the first half. FY26 guidance RAISED to $7.10-$7.20 adjusted...

Symbotic Inc. (SYM) Q3 FY2026 — Fiscal Q3 2026 (quarter ended June 27, 2026): revenue $720.8M, up 21.7% and ~0.8% ahead of a $715.0M estimate. Class A diluted EPS $0.09 against a $0.1311 consensus - a 31% MISS. Net income $55.0M vs a $21.2M loss, but $43.3M of it was allocated to noncontrolling interests and $19.4M was a non-cash gain on strategic investments. Adjusted EBITDA $95.2M, more than dou...